Pfizer (PFE), Moderna (MRNA) Covid Booster Vaccines Greenlighted by CDC Panel - Bloomberg
Study backs efficacy of half-dosage mRNA booster| สำนักข่าวกรมประชาสัมพันธ์
Effectiveness of mRNA vaccine boosters against infection with the SARS-CoV-2 omicron (B.1.1.529) variant in Spain: a nationwide cohort study - The Lancet Infectious Diseases
COVID-19 mRNA booster provides additional protection, most beneficial for older adults
Boosting with updated COVID-19 mRNA vaccines | Nature Medicine
Centers for Disease Control and Prevention on LinkedIn: CDC recommends Novavax's non-mRNA booster for people ages 18 and older…
India-made mRNA vaccine priced at ₹2,292, will be available as a booster dose - The Hindu
Safety of the fourth COVID-19 BNT162b2 mRNA (second booster) vaccine: a prospective and retrospective cohort study - The Lancet Respiratory Medicine
Effectiveness of mRNA vaccine boosters against infection with the SARS-CoV-2 omicron (B.1.1.529) variant in Spain: a nationwide cohort study - The Lancet Infectious Diseases
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing ...
Study: Booster dose of mRNA COVID vaccine prompts strong T cell response in immunocompromised patients
Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice - ScienceDirect
CDC - UPDATED: CDC updated booster recommendations for... | Facebook
Vaccini a mRNA Anti COVID-19: Come Funzionano, Efficacia e Sicurezza
Moderna on X: "A 50 µg #booster dose of our first bivalent booster #vaccine candidate, mRNA-1273.211, demonstrated superiority against Beta, Delta and #Omicron variants of concern one month after administration, and superiority
Safety Monitoring of COVID-19 mRNA Vaccine Second Booster Doses Among Adults Aged ≥50 Years — United States, March 29, 2022–July 10, 2022 | MMWR
Three mRNA COVID-19 vaccine doses very effective in protecting against emergency department visits and hospitalizations associated with Omicron and Delta variants
Durability of Booster mRNA Vaccine against SARS-CoV-2 BA.2.12.1, BA.4, and BA.5 Subvariants | NEJM
SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination | NEJM
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant - ScienceDirect
Plug and Play” mRNA technology works fast, updating vaccines in months : Oregon Health News Blog
CDC - COVID-19 BOOSTER UPDATE: Everyone ages 18+ is eligible for a COVID-19 booster. If you got an mRNA vaccine, either Pfizer-BioNTech or Moderna, you may get a booster dose 6 months
JCI - Durability of immune responses to mRNA booster vaccination against COVID-19
Study highlights the importance of bivalent mRNA booster vaccination in populations at high risk of severe COVID-19
Safety, immunogenicity, and efficacy of the mRNA vaccine CS-2034 as a heterologous booster versus homologous booster with BBIBP-CorV in adults aged ≥18 years: a randomised, double-blind, phase 2b trial - The Lancet
